Antisense Oligonucleotide Therapy for an Ultra-Rare Neurological Variant: A Case Report. Translational Medicine & Therapeutics Journal, [S. l.], v. 1, n. 1, p. 37–45, 2022. DOI: 10.5281/zenodo.22648851. Disponível em: https://inkwise.org/index.php/TMTJ/article/view/68. Acesso em: 5 nov. 2026.